Article info

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study

Authors

  1. Correspondence to Professor Robert B M Landewé, Amsterdam Rheumatology Center, AMC, Amsterdam, NL 6231, The Netherlands; landewe{at}rlandewe.nl
View Full Text

Citation

Landewé RBM, Poddubnyy D, Rahman P, et al
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study

Publication history

  • First published September 13, 2022.
Online issue publication 
January 23, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.